SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039118
Filing Date
2023-08-07
Accepted
2023-08-07 16:36:18
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20230630.htm   iXBRL 10-Q 3428758
2 EX-3.1 dawn-ex3_1.htm EX-3.1 105918
3 EX-31.1 dawn-ex31_1.htm EX-31.1 16843
4 EX-31.2 dawn-ex31_2.htm EX-31.2 16617
5 EX-32.1 dawn-ex32_1.htm EX-32.1 10022
6 EX-32.2 dawn-ex32_2.htm EX-32.2 11268
7 GRAPHIC img12642811_0.jpg GRAPHIC 126204
  Complete submission text file 0000950170-23-039118.txt   12361265

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20230630_cal.xml EX-101.CAL 38926
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20230630_pre.xml EX-101.PRE 430438
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20230630_def.xml EX-101.DEF 319147
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20230630.xsd EX-101.SCH 64961
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20230630_lab.xml EX-101.LAB 472396
64 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20230630_htm.xml XML 2564929
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 231148102
SIC: 2834 Pharmaceutical Preparations